Skip to main content

cannabidiol (Epidyolex®)

 

Appraisal in progress

Indication

Status: In progress

Adjunctive therapy of seizures associated with tuberous sclerosis complex (TSC) for patients 2 years of age and older.

 Preliminary Recommendation: cannabidiol (Epidyolex) 3201 (PDF, 20Kb)
 Company Response to Preliminary Recommendation: cannabidiol (Epidyolex) 3201 (PDF, 16Kb)
 Appraisal Report: cannabidiol (Epidyolex) 3201 (PDF, 416Kb)

Medicine details

Medicine name cannabidiol (Epidyolex®)
Formulation 100 mg/ml oral solution
Reference number 3201
Indication

As above

Company GW Pharmaceuticals Plc
BNF chapter Central nervous system
Submission type Full
Status In progress
NMG meeting date 03/11/2021
AWMSG meeting date 08/12/2021
Date of issue TBC
Commercial arrangement PAS